EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel β-lactam–Octenidine nanoGUMBOS: A promising platform to address Bacteria linked to chronic wound infections

Fátima A R Mota, Fábio M S Costa, Ana Isabel Barbosa, Andreia Granja, Salette Reis, Mariana Ferreira, Paula Gameiro, Marieta Passos, João L M Santos, M Lúcia M F S Saraiva

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Fátima A R Mota und 9 weiteren Autor:innen. Beteiligte Einrichtung: LAQV-REQUIMTE, Laboratório de Química Aplicada, Faculdade de Farmácia da Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactams, Pyridines, Wound Infection. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, European Social Fund Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a global health challenge, particularly in chronic wounds (CW), where bacterial colonization and biofilm formation impair healing and promote persistent infections. The limited efficacy of conventional antibiotics against multidrug-resistant pathogens highlights the need for innovative antimicrobial strategies. This study aimed to develop and evaluate β-lactam-octenidine nanoGUMBOS as multifunctional antimicrobial nanomaterials for CW management. Three nanoGUMBOS, [OCT][Cftx], [OCT][Cflt], and [OCT][Cfpz], were synthesized through a simple additive-free reprecipitation method. Their physicochemical properties were characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Cytocompatibility was assessed in fibroblasts (L929) and keratinocytes (HaCaT) cell lines, while antibacterial activity was evaluated against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, through minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. DLS and TEM analyses confirmed the formation of homogeneous spherical nanoparticles with diameters of approximately 100 nm and low polydispersity (PDI < 0.2). All compounds were non-cytotoxic up to 9 μM and exhibited higher cell viability than their precursor salts. [OCT][Cftx] and [OCT][Cflt] showed the strongest antibacterial activity, with MIC values as low as 4.5 μM, outperforming both bulk GUMBOS and individual precursors. This study introduces a new class of multifunctional antimicrobial nanoGUMBOS, demonstrates that nanoscale assembly enhances the antimicrobial performance of β-lactam-octenidine GUMBOS while maintaining favorable cytocompatibility. To the best of our knowledge, this is the first report of β-lactam-octenidine nanoGUMBOS, obtained through a simple, automatic and additive-free synthesis approach, highlighting their potential as a promising platform for the treatment of CW, compared with both bulk GUMBOS and precursor compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial Agentsbeta-LactamsPyridinesWound InfectionStaphylococcus aureusEscherichia coliMicrobial Sensitivity TestsHumansPseudomonas aeruginosaMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugAnimalsCell LineCell Survivalbeta Lactam AntibioticsImines

Stichwörter der Autor:innen

Antibacterial activityAntimicrobial resistanceChronic woundsCytocompatibilityNanostructured materialsnanoGUMBOS synthesisΒ-Lactam–octenidine nanoGUMBOS

Substanzen

Anti-Bacterial Agentsbeta-LactamsPyridinesoctenidinebeta Lactam AntibioticsImines

Autor:innen und Institutionen

  • LAQV-REQUIMTE, Laboratório de Química Aplicada, Faculdade de Farmácia da Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal.
  • LAQV-REQUIMTE (Laboratório Associado para a Química Verde-Rede de Química e Tecnologia), Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, s/n, 4169-007, Porto, Por…
  • LAQV-REQUIMTE, Laboratório de Química Aplicada, Faculdade de Farmácia da Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal. Electronic address: lsaraiva@ff.up.pt.

Förderung

  • Fundação para a Ciência e a Tecnologia
  • European Social Fund Plus

Zitieren

APA

Mota, F. A. R., Costa, F. M. S., Barbosa, A. I., Granja, A., Reis, S., Ferreira, M., Gameiro, P., Passos, M., Santos, J. L. M., & Saraiva, M. L. M. F. S. (2026). Novel β-lactam–Octenidine nanoGUMBOS: A promising platform to address Bacteria linked to chronic wound infections. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110503

Vancouver

Mota FAR, Costa FMS, Barbosa AI, Granja A, Reis S, Ferreira M, et al. Novel β-lactam–Octenidine nanoGUMBOS: A promising platform to address Bacteria linked to chronic wound infections. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110503

BibTeX
@article{Mota2026,
  author = {Mota, Fátima A R and Costa, Fábio M S and Barbosa, Ana Isabel and Granja, Andreia and Reis, Salette and Ferreira, Mariana and Gameiro, Paula and Passos, Marieta and Santos, João L M and Saraiva, M Lúcia M F S},
  title = {Novel β-lactam–Octenidine nanoGUMBOS: A promising platform to address Bacteria linked to chronic wound infections},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110503}
}
Kostenlos starten →